SEC Form 4 · accession 0001615774-15-003558
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan Will McGuire
Officer — Chief Executive Officer · Director
Period of report
Dec 1, 2015
Accepted (ET)
Dec 3, 2015 · 4:27 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units (RSUs)F1,F2 | — | Dec 1, 2015 | A | 190,000 | A | — | — | Common Stock | 190,000 | 190,000 | D |
Explanation of responses
- F1Each Restricted Stock Unit represents a contingent right to receive one share of EYES common stock.
- F2Restricted Stock Units granted pursuant to Second Sight Medical Products, Inc. Equity Incentive Plan - Restricted Stock Units. The RSUs will vest over four years, with 25% of the underlying shares vesting on August 18, 2016 and thereafter vesting in 12 equal installments of 6.25% on the next 12 quarterly periods. Vested shares will be delivered to the reporting person on the vesting date, provided that delivery may be delayed pursuant to the terms of the award agreement.
Remarks
Excludes employee options, covering 420,000 shares, with an exercise price of $12.43 per share, vesting over four years, with 25% of the underlying shares vesting on August 18, 2016 and thereafter vesting in 12 equal installments of 6.25% on the next 12 quarterly periods.